Forbes Irving joined last autumn to grow GCI's ethical pharma and medical education business. He is now 'considering options', and says: 'Med ed-led PR is the way the industry is going'.
GCI UK and Europe chairman Adrian Wheeler described Forbes Irving's exit as 'sad but amicable' following 'quite long discussions'. He will not be hunting a replacement.
GCI's European healthcare PROs will now work 'ever more closely' with medical education units in sister firm Grey Healthcare Group - such as Phase V in the US, the UK's Darwin Grey, and outfits in Spain and Germany - as the agency bids to promote an integrated operation to clients.
Prior to GCI, Forbes Irving spent three years as senior V-P at medical education outfit Health Learning Systems, part of CommonHealth, in New Jersey.
In a separate move, GCI Healthcare last week hired Christina Chale as an account director. She is overseeing the agency's corporate accounts for consumer healthcare firm SSL and homeopathic remedy specialist Nelsonbach, reporting to MD Rhonda Smith.
She joins from Munro & Forster Communications, where she was a senior account manager and worked for clients such as Pfizer Consumer Healthcare and Kellogg's.